We elucidate distinct gene expression profiles of tumor cells in unpaired primary and metastatic ER+ breast cancer samples while identifying specific subtypes of stromal and immune cells that may collectively contribute to developing an immunosuppressive microenvironment within metastatic tumors. This evidence concerns the gene ESR1 and breast cancer.